Isolation and identification of a novel sildenafil analogue adulterated in dietary supplements

Journal of Food and Drug Analysis

Volumn 16, Issue 4, 2008, Pages 15-20

  Lin, Mei Chih ^a   Liu, Yi Chu ^a   Lin, Yun Lian ^b   Lin, Jer Huei ^a  

^a Executive Yuan   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Acetildenafil; Dietary supplements; IR; Mass spectrum; NMR; Sildenafil; Sildenafil analogue

Indexed keywords

5 [2 ETHOXY 5 ACETYLPHENYL] 1 METHYL 3 N PROPYL 1,6 DIHYDRO 7H PYRAZOLO[4,3 D]PYRIMIDIN 7 ONE; ACETILDENAFIL; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; FOOD CONTAMINATION; INFRARED SPECTROMETRY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEPARATION TECHNIQUE; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY;

EID: 55049128616     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.38212/2224-6614.2340     Document Type: Article

References (15)

1. Zou, P., Oh, S. S., Hou, P., Lowb, M. Y. and Koh, H. L. 2006. Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A 1104: 113-122.
2. Lin, M. C., Liu, Y. C. and Lin, J. H. 2006. Identification of a sildenafil analogue adulterated in two herbal food supplements. J. Food Drug Anal. 14: 260-264.
3. Lai, K. C., Liu, Y. C., Tseng, M. C. and Lin, J. H. 2006. Isolation and Identification of a sildenafil analogue illegally added in dietary supplements. J. Food Drug Anal. 14: 19-23.
4. Zhu, X., Xiao, S., Chen, B., Zhang, F., Yao, S., Wan, Z., Yang, D. and Han, H. 2005. Simultaneous determination of sildenafil, vardenafil and tadalafil as forbidden components in natural dietary supplements for male sexual potency by high-performance liquid chromatography - electrospray ionization mass spectrometry. J. Chromatogr. A 1066: 89-95.
5. Fleshner, N., Harvey, M., Adomat, H., Wood, C., Eberding, A., Hersey, K. and Guns, E. 2005. Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase type 5 inhibitors. J. Urol. 174: 636-641.
6. Gratz, S. R., Flurer, C. L. and Wolnik, K. A. 2004. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC-ESI-MS and LC-UV. J. Pharm. Biomed. Anal. 36: 525-533.
7. Shin, C. S., Hong, M. K., Kim, D. Y. and Lim, Y. G. 2004. Structure determination of a sildenafil analogue contained in commercial herb drinks. Magn. Reson. Chem. 42: 1060-1062.
8. Blok-Tip, L., Zomer, B., Bakker, F., Hartog, K. D., Hanizink, M., Ten Hove, J., Vredenbregt, M. and De Kaste, D. 2004. Structure elucidation of sildenafil analogues in herbal products. Food Addit. Contam. 21: 737-748.
9. Shin, M. H., Hong, M. K., Kim, W. S., Lee, Y. J. and Jeoung, Y. C. 2003. Identification of a new analogue of sildenafil added illegally to a functional food marketed for penile erectile dysfunction. Food Addit. Contam. 20: 793-796.
10. Mikami, E., Ohno, T. and Matsumoto, H. 2002. Simultaneous identification/ determination system for phentolamine and sildenafil as adulterants in soft drinks advertising roborant nutrition. Forensic Sci. Int. 130: 140-146.
11. Tseng, M. C. and Lin, J. H. 2002. Determination of sildenafil citrate adulterated in a dietary supplement capsule by LC/MS/MS. J. Food Drug Anal. 10: 112-119.
12. Moriyasu, T., Shigeoka, S., Kishmoto, K., Ishikawa, F., Nakajima, J., Kamimura, H. and Yasuda, I. 2001. Identification system for sildenafil in health foods. Yakugaku Zasshi 121: 765-769.
13. Montorsi, F., Salonia, A., Briganti, A., Carrier, S., Denne, J. S., Walker, D. J., Shen, W. and Cordell, W. H. 2005. Vardenafil for the treatment of erectile dysfunction: A critical review of the literature based on personal clinical experience. Eur. Urol. 47: 612-621.
14. Carson, C. C., Rajfer, J., Eardley, I., Barbien, L., Zanni, G., Suardi, N., Cestari, A., Montorsi, P. and Rigatti, P. 2004. The efficacy and safety of tadalafil: An update. BJU Int. 93: 1276-1281.
15. Rosen, R. C. and Kostis, J. B. 2003. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. Am. J. Cardiol. 92: 9M-18M.